BG
B Group, Inc. disclosed a 10% stake in RTSN
B Group, Inc. reported owning 10% of Retension Pharmaceuticals, Inc. (RTSN) (833,333 shares) in a Schedule 13G filed Oct 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 16, 2026
- Source
- Schedule 13G